Narikazu Boku

Randomized Phase III Trial of Adjuvant Chemotherapy with Gemcitabine versus S-1 in Patients with Resected Pancreatic Cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01)

Atsuyuki Maeda, Narikazu Boku, Akira Fukutomi et al. · Japanese Journal of Clinical Oncology · 2008 · 102 citations · Full text

Medicine, Oncology, Surgery +12

A Multi-center Retrospective Analysis of Survival Benefits of Chemotherapy for Unresectable Biliary Tract Cancer

Naohiro Yonemoto, J. Furuse, T. Okusaka et al. · Japanese Journal of Clinical Oncology · 2007 · 89 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506

Hiroshi Ishii, J. Furuse, Narikazu Boku et al. · Japanese Journal of Clinical Oncology · 2010 · 67 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Feasibility Study of Single Agent Cisplatin and Concurrent Radiotherapy in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck: Preliminary Results

Sadamoto Zenda, Yusuke Onozawa, Makoto Tahara et al. · Japanese Journal of Clinical Oncology · 2007 · 61 citations · Full text

Medicine, Oncology, Radiation Oncology +12

Safety, Efficacy and Pharmacokinetics of Neratinib (HKI-272) in Japanese Patients with Advanced Solid Tumors: A Phase 1 Dose-escalation Study

Masahiro Suenaga, Kiyohiko Hatake, S. Takahashi et al. · Japanese Journal of Clinical Oncology · 2012 · 54 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10